Diabetes Supply

Novo Nordisk Diabetes Drug Victoza Gets EU Approval - Wall Street Journal

dBTechno

Novo Nordisk Diabetes Drug Victoza Gets EU Approval Wall Street Journal Victoza, also known as Liraglutide, belongs to a relatively new kind of diabetes drug class known as GLP-1 analogues. In contrast to conventional treatment … Novo Nordisk wins Europe OK for diabetes drugMarketWatch EU Approves Novo Nordisk's Drug For Type 2 Diabetes TreatmentAHN EU Commission Approves Victoza for Diabetes PatientsdBTechno Reuters -Wall Street Journal all 32 news articles »

This entry was posted on Saturday, July 4th, 2009 at 5:00 am and is filed under Diabetes Mellitus. You can subscribe via RSS 2.0 feed to this post's comments. You can skip to the end and leave a response. Pinging is currently not allowed.